Mc Gowan Group Asset Management, Inc. Abbott Laboratories Transaction History

Mc Gowan Group Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $7.88 Million - $9.27 Million	-74,468 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $99,262 - $116,945	912 Added 1.24%	74,468 $8.92 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $316,365 - $344,747	3,013 Added 4.27%	73,556 $8.05 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $1.38 Million - $1.67 Million	15,036 Added 27.09%	70,543 $7.68 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $4.05 Million - $5.18 Million	52,838 Added 1979.69%	55,507 $5.08 Million
Q1 2020 May 18, 2020	BUY	$62.82 - $91.86 $10,553 - $15,432	168 Added 6.72%	2,669 $210,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $165,616 - $200,230	2,501 New	2,501 $200,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mc Gowan Group Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Gowan Group Asset Management, Inc. with notifications on news.